health | GB News |
Royal Mail postal workers have accepted a 4.5 percent pay offer from the Communication Workers Union, with Business Secretary Peter Kyle calling for a big improvement in performance. Separately, a major study of 19 million people has found that younger women suffering from insomnia are three times more likely to develop breast cancer and twice as likely to get uterine cancer.
Royal Mail has reached a significant employment deal after members of the Communication Workers Union voted to accept a pay offer worth 4.5 percent. Business Secretary Peter Kyle welcomed the agreement, acknowledging that British posties work hard, but added a clear demand for a big improvement in Royal Mail performance for its loyal customers.
The deal follows a period of industrial tension that had threatened further disruption to postal services. The agreement on both working arrangements and pay is expected to bring stability to the service, though the government's insistence on improved performance suggests that the current standard of delivery is not meeting expectations.
In a separate health development, a landmark study has revealed alarming links between insomnia and cancer risk in younger women. The research, which analysed data from 19 million people aged between 18 and 50 over a five-year period, found that among 400,000 individuals diagnosed with insomnia, the cancer risks were significantly elevated.
Women with insomnia were found to be three times more at risk of developing breast cancer and twice as likely to develop uterine cancer compared to those without sleep disorders. Both cancers are hormone-related, which may explain the connection, as chronic sleep deprivation is known to disrupt the hormonal systems that regulate these tissues.
The findings add significant weight to the growing body of evidence that quality sleep is not merely a lifestyle preference but a critical factor in long-term health outcomes. For younger women in particular, addressing insomnia may prove to be an important preventive measure against some of the most common forms of cancer.